The potent colon carcinogen, 1,2-dimethylhydrazine induces mutations primarily in the colon

被引:54
作者
Newell, LE [1 ]
Heddle, JA [1 ]
机构
[1] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada
关键词
cII; Muta (TM) Mouse; cancer; Dlb-1;
D O I
10.1016/j.mrgentox.2004.06.005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1,2-Dimethylhydrazine (DMH) is a potent colon carcinogen that is commonly used as an initiator in studies of the effects of diet on colon cancer. Previous studies have shown that although this compound produces multiple tumors in the colons in most individuals of every species tested, it is, at best, marginally mutagenic in the bone marrow (micronuclei) and small intestine (Dlb-1 mutations). Here we report its mutagenicity in the primary target tissue, the colonic epithelium, by means of the Muta(TM)Mouse cII assay, an assay for intragenic mutations in a lambda shuttle vector that is integrated into the genome of these mice. Animals were treated with 0, 10, 20, or 30 mg/ml of DMH, either as a single injection or as multiple weekly injections, and mutations were measured in both the small intestine and colon. In the small intestine, there was an increase in mutant frequency following a single injection of DMH, but this was significant only at 30 mg/kg [induced mutant frequency (MF) = 18 x 10(-5) mutants/plaque]. In the colon, following a single treatment of DMH, there was a significant increase in mutant frequency at doses of 20 and 30 mg/kg (induced MF = 17 x 10(-5) and 23 x 10(-5) mutants/plaque, respectively). Following ten injections of 20 mg/kg of DMH, there was a greater than ten-fold increase in mutations in the colon (MF = 275 x 10(-5) mutants/plaque) than the small intestine (MF = 25 x 10(-5) mutants/plaque). These results show that DMH, under the conditions typically used for dietary studies, induces large numbers of mutations in the tissue in which it induces most cancers. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 19 条
  • [11] MASKENS AP, 1976, CANCER RES, V36, P1585
  • [12] Stability of CII is a key element in the cold stress response of bacteriophage lambda infection
    Obuchowski, M
    Shotland, Y
    Koby, S
    Giladi, H
    Gabig, M
    Wegrzyn, G
    Oppenheim, AB
    [J]. JOURNAL OF BACTERIOLOGY, 1997, 179 (19) : 5987 - 5991
  • [13] RONEN A, 1984, CANCER RES, V44, P1536
  • [14] Swiger RR, 1999, ENVIRON MOL MUTAGEN, V34, P201, DOI 10.1002/(SICI)1098-2280(1999)34:2/3<201::AID-EM20>3.0.CO
  • [15] 2-P
  • [16] THE ACCUMULATION AND PERSISTENCE OF SOMATIC MUTATIONS IN-VIVO
    TAO, KS
    HEDDLE, JA
    [J]. MUTAGENESIS, 1994, 9 (03) : 187 - 191
  • [17] COMPARISON OF SOMATIC MUTATION IN A TRANSGENIC VERSUS HOST LOCUS
    TAO, KS
    URLANDO, C
    HEDDLE, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) : 10681 - 10685
  • [18] ZAR J. H, 1984, BIOSTAT ANAL, P718
  • [19] Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and amino(alpha)carboline
    Zhang, XB
    Felton, JS
    Tucker, JD
    Urlando, C
    Heddle, JA
    [J]. CARCINOGENESIS, 1996, 17 (10) : 2259 - 2265